Patrick R. Hagner

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma”.

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

Blood Cancer Journal(2023)10.1038/s41408-023-00787-w

N/A

0DataRank · unranked

17 citations

Anna James-Bott, Mark A. Tye, Leona Yamamoto, Mehmet Samur, Yu‐Tzu Tai +24 more

Data from Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma

(2023)10.1158/0008-5472.c.6500028.v1

N/A

0DataRank · unranked

0 citations

X. Frank Zhao, Patrick R. Hagner, Paul R. Shapiro, Krystyna Mazan-Mamczarz, Shuchun Zhao +3 more

Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

Nature Communications(2024)10.1038/s41467-024-50830-y

N/A

0DataRank · unranked

17 citations

Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew J. Maurer +23 more